Donald Trump's decisive re-election as US President on Nov 5 puts many aspects of health and science in a deeply concerning position. Although there is broader alarm about his openly authoritarian ...

Industry leaders in health and science converged in downtown Raleigh Thursday to highlight the area’s latest advancements in ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

U.S. policies that fix the IRA, strengthen patents, and incentivize antimicrobial research could help hasten new medicines ...

A study in the Journal of the American Chemical Society reports steps toward making inhalable mRNA medicines a possibility.

In this talk, Rasu Shrestha, Enterprise Executive Vice President and Chief Innovation and Commercialization Officer for ...

In the world of nuclear medicine, health care professionals face the challenge of safeguarding themselves and their patients ...

Setting Interviews were conducted in a large academic medical centre from June–September 2021 ... The results provide a foundation for the design of future feedback initiatives to optimise both ...

What will the medical publications of the future look like? Russell Traynor addresses this question by first exploring the importance of medical publications and what it is we actually need from them.

“I think the future role of AI in research is becoming more significant.” Where previously there was an interaction between a human and computer, the paradigm has shifted towards a human-foundation ...

Discounting future FCF from operations in a similar manner to discounting dividends is one such valuation model. What are free cash flows? Free cash flows refer to the cash a company generates ...